// App-Quantinova.ai

PO1018 : Efficacy and Safety of Cotadutide, a Dual GLP-1 and Glucagon Receptor Agonist, for Patients with Type 2 Diabetes Mellitus and CKD

Researchers

Presenter

  • Parker VictoriaEr

Principal Investigators

  • Hoang Thuong

  • Schlichthaar Heike

  • Chang Yi-Ting

  • Petrone Marcella

  • Hansen Lars

  • Ambery PhilipD

  • L Heerspink HiddoJan

  • Mccrimmon Rory

  • Jermutus Lutz

Medical Centers

  • Astra Zeneca, Cambridge, United Kingdom

  • Study Center SMO.MD GmbH Magdeburg Germany

  • AstraZeneca Gaithersburg Maryland United States

  • AstraZeneca, Gothenburg, Sweden

  • University Medical Center Groningen, Nijmegen, Netherlands

  • School of Medicine University of Dundee Ninewells Hospital Dundee United Kingdom

Locations

  • United Kingdom

  • Germany

  • United States

  • Sweden

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

  • Chronic kidney disease

  • Diabetes

  • Renal disease

Biomarkers

  • C-peptide

  • Creatinine

  • Hemoglobin A1c

  • Human albumin

  • Body mass index

Drug/Treatment

  • Intranasal glucagon

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved